Another variant vaccine, another potential risk
With the availability of the latest Pfizer (COMIRNATY®) Omicron XBB.1.5 vaccine, indicated for 12 years and over, there may be potential for selection or administration
Practice Alerts COVID-19
With the availability of the latest Pfizer (COMIRNATY®) Omicron XBB.1.5 vaccine, indicated for 12 years and over, there may be potential for selection or administration
Disclaimer: This article was published in 2022 and reflects the information available at that time. The recent availability of the Moderna Spikevax Bivalent Booster
Disclaimer: This article was published in 2022 and reflects the information available at that time. The recent surge in demand for influenza vaccines has
Disclaimer: This article was published in 2022 and reflects the information available at that time. As winter approaches, pharmacies will be very busy providing
Disclaimer: This article was published in 2022 and reflects the information available at that time. The ATAGI approval of Moderna Spikevax for the primary
Disclaimer: This article was published in 2021 and reflects the information available at that time. The approval of the Pfizer Comirnaty Orange Cap (5-11 years) COVID-19 vaccine to be administered
Disclaimer: This article was published in 2021 and reflects the information available at that time. Vaccinating pharmacists take note… The Moderna Spikevax vaccine has
Disclaimer: This article was published in 2021 and reflects the information available at that time. The PDL Professional Officers have noted a recent reduction
Disclaimer: This article was published in 2021 and reflects the information available at that time. PDL recognises the extraordinary efforts that pharmacists have made
Disclaimer: This article was published in 2021 and reflects the information available at that time. The PDL Professional Officers continue to assist pharmacists with